Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karl-August Ackermann is active.

Publication


Featured researches published by Karl-August Ackermann.


Bioorganic & Medicinal Chemistry Letters | 1994

EMD 61 753 as a favourable representative of structurally novel arylacetamido-type K opiate receptor agonists

Rudolf Gottschlich; Karl-August Ackermann; Andrew Barber; Gerd Bartoszyk; Hartmut Greiner

Abstract K opiate agonists like (−)-U 50488H, (−)-PD 117302, etc. contain an acetamido group which is mono substituted in the α-position by an aromatic moiety. In contrast, EMD 61 753 is di substituted in this position by two phenyl rings and is thus the first representative of the new class of diarylacetamide-type κ opiates. Derivatives of EMD 61 753 are described and structure-activity relationships are discussed. In the formalin test in mice EMD 61 753 shows a profile similar to that of the antiinflammatory drugs rather than that of the centrally acting opiates.


Archive | 1991

1-(2-Arylethyl)-pyrrolidine

Rudolf Gottschlich; Karl-August Ackermann; Helmut Prücher; Andrew Barber; Anton Dr. Haase; Hartmut Dr Greiner; Gerd Bartoszyk


Archive | 2000

Imidazopyridine derivatives as phosphodiesterase VII inhibitors

Hanse-Michael Eggenweiler; Karl-August Ackermann; Rochust Jonas; Michael Wolf; Michael Gassen; Thomas Welge


Archive | 2004

Urea derivatives and their use as tyrosinkinase inhibitors

Günter Hoelzemann; Karl-August Ackermann; Wolfgang Staehle; Alfred Jonczyk; Wilfried Rautenberg; Helerie Crassier; Francesc Mitjans; Elisabet Rosell-Vives; Jaume Adan; Marta Soler Riera


Archive | 1989

Nitrogen-containing cyclic compounds

Rudolf Gottschlich; Helmut Prücher; Karl-August Ackermann; Andrew Barber; Hartmut Dr Greiner; Anton Dr. Haase


Archive | 1999

Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrolidine-1-yl)ethyl]-2,2-diphenylacetamide

Andreas Bathe; Bernd Helfert; Karl-August Ackermann; Rudolf Gottschlich; Ingeborg Stein; Jens Budak


Archive | 1997

Quinolin-2-(1H)-ones

Karl-August Ackermann; Rudlof Gottschlich; Günter Hölzemann; Joachim Leibrock; Wilfried Rautenberg; Christoph Seyfried


Archive | 2005

4-amino-5-oxo-8-phenyl-5h-pyrido[2,3-d]pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours

Guenter Hoelzemann; Karl-August Ackermann; Helene Crassier; Alfred Jonczyk; Wilfried Rautenberg; Gema Tarrason; Elisabet Rosell-Vives; Jaume Adan; Claudia Cases


Archive | 1997

Chinoline-2-(1h)-ones

Karl-August Ackermann; Rudolf Gottschlich; Günter Hölzemann; Joachim Leibrock; Wilfried Rautenberg; Christoph Seyfried


Archive | 1999

METHOD FOR PRODUCING ENANTIOMERICALLY PURE N-METHYL-N- (1S)-1-PHENYL- 2-((3S)- 3-HYDROXYPYRROLIDINE- 1-YL)ETHYL]- 2,2-DIPHENYL ACETAMIDE

Karl-August Ackermann; Andreas Bathe; Jens Budak; Rudolf Gottschlich; Bernd Helfert; Ingeborg Stein

Collaboration


Dive into the Karl-August Ackermann's collaboration.

Researchain Logo
Decentralizing Knowledge